Treatment of aggressive basal cell carcinoma with intralesional interferon: Evaluation of efficacy by Mohs surgery
- 31 July 1992
- journal article
- Published by Elsevier BV in Journal of the American Academy of Dermatology
- Vol. 27 (1), 65-69
- https://doi.org/10.1016/0190-9622(92)70158-c
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Intralesional interferon alfa-2b in the treatment of basal cell carcinoma: Immunohistochemical study on cellular immune reaction leading to tumor regressionJournal of the American Academy of Dermatology, 1991
- The effect of intralesional interferon gamma on basal cell carcinomasJournal of the American Academy of Dermatology, 1990
- Intralesional interferon therapy for basal cell carcinomaJournal of the American Academy of Dermatology, 1990
- Interferon. Coming of ageArchives of Dermatology, 1990
- Treatment of neoplastic skin lesions with intralesional interferonJournal of the American Academy of Dermatology, 1989
- TREATMENT OF LARGE BASAL-CELL CARCINOMAS WITH INTRALESIONAL INTERFERON-ALPHA-2aThe Lancet, 1988
- Interferon. Promises, disappointments, and tempered optimismArchives of Dermatology, 1987
- Treatment of basal cell carcinoma with intralesional interferonJournal of the American Academy of Dermatology, 1986
- Measurement and Figure in DermatologyArchives of Dermatology, 1986
- Mohs surgery. Technique, indications, applications, and the futureArchives of Dermatology, 1983